Caribou Biosciences (CRBU) Enterprise Value: 2020-2025
Historic Enterprise Value for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $69.7 million.
- Caribou Biosciences' Enterprise Value rose 234.51% to $69.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$532.2 million, marking a year-over-year increase of 38.37%. This contributed to the annual value of -$65.6 million for FY2024, which is 136.85% down from last year.
- As of Q3 2025, Caribou Biosciences' Enterprise Value stood at $69.7 million, which was up 204.43% from -$66.8 million recorded in Q2 2025.
- Caribou Biosciences' 5-year Enterprise Value high stood at $996.2 million for Q3 2021, and its period low was -$145.9 million during Q1 2021.
- Moreover, its 3-year median value for Enterprise Value was $20.8 million (2024), whereas its average is $25.4 million.
- In the last 5 years, Caribou Biosciences' Enterprise Value skyrocketed by 4,158.31% in 2021 and then plummeted by 5,534.89% in 2024.
- Quarterly analysis of 5 years shows Caribou Biosciences' Enterprise Value stood at $532.5 million in 2021, then slumped by 83.08% to $90.1 million in 2022, then surged by 97.43% to $177.9 million in 2023, then crashed by 136.85% to -$65.6 million in 2024, then soared by 234.51% to $69.7 million in 2025.
- Its Enterprise Value stands at $69.7 million for Q3 2025, versus -$66.8 million for Q2 2025 and -$123.5 million for Q1 2025.